Sterling TR - Search Results

1

Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection.

Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR. Vlahov D, et al. Among authors: sterling tr. Am J Epidemiol. 2005 Jun 1;161(11):999-1012. doi: 10.1093/aje/kwi133. Am J Epidemiol. 2005. PMID: 15901620 Free PMC article. Clinical Trial.

2

Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.

Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. Sterling TR, et al. AIDS. 1998 Aug 20;12(12):1451-7. doi: 10.1097/00002030-199812000-00006. AIDS. 1998. PMID: 9727565

3

Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters.

Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, Quinn TC. Sterling TR, et al. J Infect Dis. 1999 Sep;180(3):666-72. doi: 10.1086/314967. J Infect Dis. 1999. PMID: 10438353

4

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Sterling TR, et al. N Engl J Med. 2001 Mar 8;344(10):720-5. doi: 10.1056/NEJM200103083441003. N Engl J Med. 2001. PMID: 11236775 Free article.

5

Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.

Sadaphal P, Astemborski J, Graham NM, Sheely L, Bonds M, Madison A, Vlahov D, Thomas DL, Sterling TR. Sadaphal P, et al. Among authors: sterling tr. Clin Infect Dis. 2001 Nov 15;33(10):1687-91. doi: 10.1086/323896. Epub 2001 Oct 12. Clin Infect Dis. 2001. PMID: 11641824 Free PMC article.

6

Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.

Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J. Sterling TR, et al. J Infect Dis. 2002 Oct 15;186(8):1181-5. doi: 10.1086/343807. Epub 2002 Sep 30. J Infect Dis. 2002. PMID: 12355373 Free article.

7

Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.

Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. Wang C, et al. Among authors: sterling tr. J Infect Dis. 2004 Sep 15;190(6):1046-54. doi: 10.1086/422848. Epub 2004 Aug 17. J Infect Dis. 2004. PMID: 15319852

8

Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART eras.

Galai N, Vlahov D, Bareta JC, Wang C, Cohn S, Sterling TR. Galai N, et al. Among authors: sterling tr. J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):74-81. doi: 10.1097/00126334-200501010-00014. J Acquir Immune Defic Syndr. 2005. PMID: 15608529

9

Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals.

Sterling TR, Pisell-Noland T, Perez JL, Astemborski J, McGriff JR, Nutting L, Hoover DR, Vlahov D, Bollinger RC. Sterling TR, et al. J Infect Dis. 2005 Mar 15;191(6):881-5. doi: 10.1086/427827. Epub 2005 Feb 7. J Infect Dis. 2005. PMID: 15717262

10

Serum albumin as a prognostic indicator for HIV disease progression.

Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Mehta SH, et al. Among authors: sterling tr. AIDS Res Hum Retroviruses. 2006 Jan;22(1):14-21. doi: 10.1089/aid.2006.22.14. AIDS Res Hum Retroviruses. 2006. PMID: 16438640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters